111 related articles for article (PubMed ID: 1504303)
1. Evidence that factor VII levels correlate strongly with fibrinopeptide A release: evaluation by an ex vivo method.
Mariani G; Iacopino G; Pasquali-Lasagni R
Int J Clin Lab Res; 1992; 22(2):111-4. PubMed ID: 1504303
[TBL] [Abstract][Full Text] [Related]
2. An association between the factor VII coagulant activity and thrombin activity induced by surface/cold exposure of normal human plasma.
Miller GJ; Seghatchian MJ; Walter SJ; Howarth DJ; Thompson SG; Esnouf MP; Meade TW
Br J Haematol; 1986 Feb; 62(2):379-84. PubMed ID: 3484967
[TBL] [Abstract][Full Text] [Related]
3. Factor VII activation and oral contraceptives.
Plu-Bureau G; Scarabin PY; Bara L; Malmejac A; Guize L; Samama M
Thromb Res; 1993 May; 70(3):275-80. PubMed ID: 8327993
[TBL] [Abstract][Full Text] [Related]
4. Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients.
Kurantsin-Mills J; Ofosu FA; Safa TK; Siegel RS; Lessin LS
Br J Haematol; 1992 Aug; 81(4):539-44. PubMed ID: 1390242
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological and genetic associations of activated factor XII concentration with factor VII activity, fibrinopeptide A concentration, and risk of coronary heart disease in men.
Zito F; Drummond F; Bujac SR; Esnouf MP; Morrissey JH; Humphries SE; Miller GJ
Circulation; 2000 Oct; 102(17):2058-62. PubMed ID: 11044420
[TBL] [Abstract][Full Text] [Related]
6. Thrombin generation measurement in factor VII-depleted plasmas compared to inherited factor VII-deficient plasmas.
Giansily-Blaizot M; Al Dieri R; Schved JF
Pathophysiol Haemost Thromb; 2003; 33(1):36-42. PubMed ID: 12853711
[TBL] [Abstract][Full Text] [Related]
7. Purification and characterization of a coagulant enzyme, okinaxobin I, from the venom of Trimeresurus okinavensis (Himehabu snake) which releases fibrinopeptide B.
Iwasaki A; Shieh TC; Shimohigashi Y; Waki M; Kihara H; Ohno M
J Biochem; 1990 Nov; 108(5):822-8. PubMed ID: 1964457
[TBL] [Abstract][Full Text] [Related]
8. Thrombin generation during collection of blood from donors taking oral contraceptives.
Skjønsberg OH; Kierulf P; Engebretsen LF; Gjønnes G; Godal HC
Vox Sang; 1987; 52(1-2):31-5. PubMed ID: 2955572
[TBL] [Abstract][Full Text] [Related]
9. The effects of quality and timing of venepuncture on markers of blood coagulation in healthy middle-aged men.
Miller GJ; Bauer KA; Barzegar S; Foley AJ; Mitchell JP; Cooper JA; Rosenberg RD
Thromb Haemost; 1995 Jan; 73(1):82-6. PubMed ID: 7740501
[TBL] [Abstract][Full Text] [Related]
10. Effects of long-term gestodene-containing oral contraceptive administration on hemostasis.
Abbate R; Pinto S; Rostagno C; Bruni V; Rosati D; Mariani G
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):424-9. PubMed ID: 2372036
[TBL] [Abstract][Full Text] [Related]
11. Monitoring thrombin generation with prothrombin fragment 1.2 assay during cardiopulmonary bypass surgery.
Knudsen L; Hasenkam JM; Kure HH; Hughes P; Bellaiche L; Ahlburg P; Djurhuus C
Thromb Res; 1996 Oct; 84(1):45-54. PubMed ID: 8885146
[TBL] [Abstract][Full Text] [Related]
12. Activation of blood coagulation in Crohn's disease. Increased plasma fibrinopeptide A levels and enhanced generation of monocyte tissue factor activity.
Edwards RL; Levine JB; Green R; Duffy M; Mathews E; Brande W; Rickles FR
Gastroenterology; 1987 Feb; 92(2):329-37. PubMed ID: 3792769
[TBL] [Abstract][Full Text] [Related]
13. Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction.
van Hulsteijn H; Kolff J; Briët E; van der Laarse A; Bertina R
Am Heart J; 1984 Jan; 107(1):39-45. PubMed ID: 6197872
[TBL] [Abstract][Full Text] [Related]
14. The role of augmented Hageman factor (factor XII) titers in the cold-promoted activation of factor VII and spontaneous shortening of the prothrombin time in women using oral contraceptives.
Gordon EM; Ratnoff OD; Jones PK
J Lab Clin Med; 1982 Mar; 99(3):363-9. PubMed ID: 7057063
[TBL] [Abstract][Full Text] [Related]
15. Fibrinopeptide A cleavage and platelet release in whole blood in vitro. Effects of stimuli, inhibitors, and agitation.
Kaplan KL; Drillings M; Lesznik G
J Clin Invest; 1981 May; 67(5):1561-8. PubMed ID: 6453136
[TBL] [Abstract][Full Text] [Related]
16. Increased activation of the haemostatic system in men at high risk of fatal coronary heart disease.
Miller GJ; Bauer KA; Barzegar S; Cooper JA; Rosenberg RD
Thromb Haemost; 1996 May; 75(5):767-71. PubMed ID: 8725721
[TBL] [Abstract][Full Text] [Related]
17. Thrombin activity and oral anticoagulant therapy: a further evaluation.
Marongiu F; Sorano GG; Mameli G; Mamusa AM; Cambuli AB; Conti M; Cadoni MC; Balestrieri A
Haemostasis; 1990; 20(1):63-4. PubMed ID: 2323681
[No Abstract] [Full Text] [Related]
18. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
Weitz JI; Cruickshank MK; Thong B; Leslie B; Levine MN; Ginsberg J; Eckhardt T
J Clin Invest; 1988 Nov; 82(5):1700-7. PubMed ID: 3141481
[TBL] [Abstract][Full Text] [Related]
19. Studies on immunological assay of vitamin K dependent factors. I. Measurement of factor VII antigen by radioimmunoassay.
Mikami S; Tuddenham EG
Br J Haematol; 1986 Jan; 62(1):171-81. PubMed ID: 3484635
[TBL] [Abstract][Full Text] [Related]
20. The strong positive correlation between factor VII clotting activity using bovine thromboplastin and the activated factor VII level.
Kario K; Matsuo T; Asada R; Sakata T; Kato H; Miyata T
Thromb Haemost; 1995 Mar; 73(3):429-34. PubMed ID: 7667824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
